Suppr超能文献

端粒间重组存在于端粒酶阳性的人类细胞中。

Inter-telomeric recombination is present in telomerase-positive human cells.

机构信息

Department for Internal Medicine I, University Hospital Innsbruck, Innsbruck, Austria.

出版信息

Cell Cycle. 2013 Jul 1;12(13):2084-99. doi: 10.4161/cc.25136. Epub 2013 Jun 6.

Abstract

Immortal cells require a mechanism of telomere length control in order to divide infinitely. One mechanism is telomerase, an enzyme that compensates the loss of telomeric DNA. The second mechanism is the alternative lengthening of telomeres (ALT) pathway. In ALT pathway cells, homologous recombination between telomeric DNA is the mechanism by which telomere homeostasis is achieved. We developed a novel homologous recombination reporter system that is able to measure inter-telomeric recombination in a sensitive manner. We asked the fundamental question if homologous recombination between different telomeres is present in telomerase-positive cells. In this in vitro study, we showed that homologous recombination between telomeres is detectable in ALT cells with the same frequency as in cells that utilize the telomerase pathway. We further described an ALT cell clone that showed peaks of recombination which were not detected in telomerase-positive clones. In telomerase-positive cells the frequency of inter-telomeric recombination was not increased by shortened telomeres or by a fragile telomere phenotype induced with aphidicolin. ALT cells, in contrast, responded to aphidicolin with an increase in the frequency of recombination. Our results indicate that inter-telomeric recombination is present in both pathways of telomere length control, but the factors that increase recombination are different in ALT and telomerase-positive cells.

摘要

永生细胞需要一种端粒长度控制机制才能无限分裂。一种机制是端粒酶,它是一种补偿端粒 DNA 损失的酶。第二种机制是端粒的替代性延长(ALT)途径。在 ALT 途径细胞中,端粒 DNA 之间的同源重组是实现端粒稳态的机制。我们开发了一种新型的同源重组报告系统,能够以敏感的方式测量端粒之间的重组。我们提出了一个基本问题,即在端粒酶阳性细胞中是否存在不同端粒之间的同源重组。在这项体外研究中,我们表明,在 ALT 细胞中,端粒之间的同源重组与利用端粒酶途径的细胞一样容易检测到。我们进一步描述了一个 ALT 细胞克隆,该克隆显示出重组峰,而在端粒酶阳性克隆中则没有检测到。在端粒酶阳性细胞中,端粒缩短或用阿霉素诱导的脆弱端粒表型并不会增加端粒间重组的频率。相比之下,ALT 细胞对阿霉素的反应是重组频率增加。我们的结果表明,端粒长度控制的两种途径中都存在端粒间重组,但在 ALT 和端粒酶阳性细胞中,增加重组的因素是不同的。

相似文献

1
Inter-telomeric recombination is present in telomerase-positive human cells.
Cell Cycle. 2013 Jul 1;12(13):2084-99. doi: 10.4161/cc.25136. Epub 2013 Jun 6.
3
Homologous recombination in human telomerase-positive and ALT cells occurs with the same frequency.
EMBO Rep. 2003 Dec;4(12):1138-43. doi: 10.1038/sj.embor.7400027. Epub 2003 Nov 14.
4
Telomere maintenance by telomerase and by recombination can coexist in human cells.
Hum Mol Genet. 2001 Sep 1;10(18):1945-52. doi: 10.1093/hmg/10.18.1945.
5
Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin.
Nucleic Acids Res. 2014 Apr;42(7):4391-405. doi: 10.1093/nar/gku114. Epub 2014 Feb 5.
6
Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
Oncogene. 1999 Jun 3;18(22):3383-90. doi: 10.1038/sj.onc.1202752.
7
Hyperextended telomeres promote formation of C-circle DNA in telomerase positive human cells.
J Biol Chem. 2023 May;299(5):104665. doi: 10.1016/j.jbc.2023.104665. Epub 2023 Mar 30.
8
9
The frequency of homologous recombination in human ALT cells.
Cell Cycle. 2004 May;3(5):547-9. Epub 2004 May 10.

引用本文的文献

1
Telomerase lost?
Chromosoma. 2016 Mar;125(1):65-73. doi: 10.1007/s00412-015-0528-7. Epub 2015 Jul 11.
2
Keeping those telomeres short! an innovative intratumoral long-term drug delivery system.
J Cancer Res Clin Oncol. 2015 Jan;141(1):23-34. doi: 10.1007/s00432-014-1747-7. Epub 2014 Jul 30.

本文引用的文献

1
Alternative lengthening of telomeres in normal mammalian somatic cells.
Genes Dev. 2013 Jan 1;27(1):18-23. doi: 10.1101/gad.205062.112.
2
Understanding telomerase in cancer stem cell biology.
Cell Cycle. 2012 Apr 15;11(8):1479-80. doi: 10.4161/cc.20108.
3
The role of telomere trimming in normal telomere length dynamics.
Cell Cycle. 2012 Apr 1;11(7):1309-15. doi: 10.4161/cc.19632.
4
A role for sister telomere cohesion in telomere elongation by telomerase.
Cell Cycle. 2012 Jan 1;11(1):19-25. doi: 10.4161/cc.11.1.18633.
5
ALTered telomeres in response to telomere dysfunction.
Cell Cycle. 2011 Nov 15;10(22):3807-9. doi: 10.4161/cc.10.22.18188.
6
Altered telomeres in tumors with ATRX and DAXX mutations.
Science. 2011 Jul 22;333(6041):425. doi: 10.1126/science.1207313. Epub 2011 Jun 30.
8
G-quadruplex nucleic acids and human disease.
FEBS J. 2010 Sep;277(17):3470-88. doi: 10.1111/j.1742-4658.2010.07760.x. Epub 2010 Jul 29.
9
Telomeres: structures in need of unwinding.
FEBS Lett. 2010 Sep 10;584(17):3760-72. doi: 10.1016/j.febslet.2010.07.007. Epub 2010 Jul 14.
10
Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers.
FEBS Lett. 2010 Sep 10;584(17):3800-11. doi: 10.1016/j.febslet.2010.06.009. Epub 2010 Jun 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验